Search bioRxiv⌕ Search

Biology subjects

Lamb, K.

Publications and source records attributed to Lamb, K..

7 recordsLinked to original sources

Protein language models learn underlying mutation biases alongside fitness landscapes

Protein language models (PLMs) score the effects of amino acid replacements as pseudo-probabilities, which are widely utilised to map protein fitness landscapes. However, because their training data relies on natural amino acid sequences, these models conflate protein structural constraints with nucleotide mutation biases and codon accessibility. Using the rapid emergence of the divergent influenza A H3N2 K lineage as a stress test, we investigate how base PLMs (ESM-2 and ESM-C) versus fine-tuned versions of these models capture mutational processes. We systematically implement a parameter sweep to explicitly couple (or decouple) empirical nucleotide mutational supply from PLM-assessed amino acid substitution pseudo-probabilities across evolutionary forecasting tasks. We find that base PLMs implicitly learn generic nucleotide-level mutational constraints, an effect strongly amplified by virus-specific fine-tuning. Incorporating explicit mutational accessibility significantly improves the binary prediction of observed amino acid changes. Conversely, when predicting the final circulating frequency of variants that have already emerged, adding mutational supply degrades performance, confirming that selection dominates post-emergence dynamics. Additionally, we perform amino-acid-level epistatic scanning to investigate protein structural constraints in the context of genetic background. This indicates the improbable antigenic substitution I160K is dependent on co-occurring S144N and N158D mutations in the H3N2 K lineage. Ultimately, current PLM pseudo-probabilities are a composite metric that conflates protein structural fitness with historical biases in mutational supply. Explicitly decoupling these independent evolutionary processes optimises predictive accuracy for real-world pathogen forecasting and isolates pure protein fitness for synthetic design pipelines.

evolutionary biology↗

Understanding the emergence of the influenza A/H3N2 K subclade in its historical and evolutionary context

The emergence in 2025/26 of the influenza A/H3N2 K substrain (H3N2/K) was the cause of significant public health concern. This genetically divergent virus was assessed to have a strongly decreased reactivity to contemporary vaccine strains. Respectively prolonged and early influenza seasons in the Southern and Northern Hemispheres contributed to concerns about vaccine efficacy. Here we retrospectively assessed the genetic and antigenic properties of this virus, combining epidemiological surveillance data, computational antigenic analysis, and serological data using samples from a well-stratified UK cohort. In contrast to initial indications, we found that despite the genetic distinctiveness of H3N2/K the virus had undergone limited antigenic change, suggesting that its emergence was instead the result of selection for non-antigenic properties. We confirmed previous results showing that contemporary vaccines produced an enhanced neutralising response to H3N2/K but, in a stratified serological analysis, showed that responses to the J and K substrains were age-dependent, largely driven by patterns of vaccination. Our results have implications for antigenic surveillance and for public communication strategies in future influenza seasons.

evolutionary biology↗

Heterogeneous evolutionary history defines the rear edge of the North American herb Campanula americana

AimWarmer range limits of species distributions offer a window into the ecological and evolutionary processes associated with long-term warming, as they often harbor relicts of refugial populations from last glaciation. However, warm-edge populations vary in their refugial, evolutionary, and climatic histories, complicating their use as models. Here, we characterize this variation at the warmer range limit of the North American herb Campanula americana. LocationEastern North America TaxonCampanula americana MethodsWe evaluated the warmer range limit using species distribution model hindcasting, range-wide analyses of population structure, effective migration and phylogenetic relationships. ResultsWarm-edge populations vary in their refugial history; most are relicts of historic refugial populations (i.e. rear edge), but some result from southward postglacial colonization. Within the rear edge, populations exhibit pronounced genetic structure, forming highly isolated clusters despite contiguous geography and only modest landscape barriers. Distinct rear-edge clusters also varied in climate history and gene flow among population, with the more southern populations experiencing higher habitat decline, fragmentation and isolation. Finally, only rear-edge populations from northern refugial areas contributed to postglacial range expansion. Main conclusionsOur study highlights the challenges of using warm-edge populations as ecological and evolutionary models of response to climate change. Even in a geographically simple setting, warm-edge populations exhibit refugial, genetic, and climatic heterogeneity. Characterizing this variation is essential for accurately identifying rear-edge populations and inferring their evolutionary history. Knowledge of the contribution of warm-edge populations to range-wide genetic variation is key when considering how these populations may inform studies of adaptation to future climate change.

evolutionary biology↗

Designer small molecule control system based on Minocycline induced disruption of protein-protein interaction.

A versatile, safe, and effective small-molecule control system is highly desirable for clinical cell therapy applications. Therefore, we developed a two-component small-molecule control system based on the disruption of protein-protein interactions using minocycline, an FDA-approved antibiotic with wide availability, excellent bio-distribution, and low toxicity. The system comprises an anti-minocycline single-domain antibody (sdAb) and a minocycline-displaceable cyclic peptide. Here we show how this versatile system can be applied to OFF-switch split CAR systems (MinoCAR) and universal CAR adaptors (MinoUniCAR) with reversible, transient, and dose-dependent suppression; to a tunable T cell activation module based on MyD88/CD40 signaling; to a controllable cellular payload secretion system based on IL-12 KDEL retention and as a cell/cell inducible junction. This work represents an important step forward in the development of a remote-controlled system to precisely control the timing, intensity, and safety of therapeutic interventions. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=125 SRC="FIGDIR/small/553207v1_ufig1.gif" ALT="Figure 1"> View larger version (57K): org.highwire.dtl.DTLVardef@1a16d73org.highwire.dtl.DTLVardef@1189ceeorg.highwire.dtl.DTLVardef@e70a57org.highwire.dtl.DTLVardef@580fa9_HPS_FORMAT_FIGEXP M_FIG C_FIG

molecular biology↗

Novel Fas-TNFR chimeras that prevents Fas ligand-mediated kill and signals synergistically to enhance CAR T-cell efficacy

The hostile tumour microenvironment limits the efficacy of adoptive cell therapies. Activation of the Fas death receptor initiates apoptosis and disrupting these receptors could be key to increase CAR T-cell efficacy. We screened a library of Fas-TNFR proteins identifying several novel chimeras that not only prevented Fas ligand-mediated kill, but also enhanced CAR T-cell efficacy by signalling synergistically with the CAR. Upon binding Fas ligand, Fas-CD40 activated the NF-{kappa}B pathway, inducing greatest proliferation and IFN{gamma} release out of all Fas-TNFRs tested. Fas-CD40 induced profound transcriptional modifications, particularly genes relating to the cell cycle, metabolism, and chemokine signalling. Co-expression of Fas-CD40 with either 4-1BB- or CD28-containing CARs increased in vitro efficacy by eliciting maximal CAR T-cell proliferation and cancer target cytotoxicity, and enhanced tumour killing and overall mouse survival in vivo. Functional activity of the Fas-TNFRs were dependent on the co-stimulatory domain within the CAR, highlighting crosstalk between signalling pathways. Furthermore, we show that a major source for Fas-TNFR activation derives from CAR T cells themselves via activation-induced Fas ligand upregulation, highlighting a universal role of Fas-TNFRs in augmenting CAR T-cell responses. We have identified Fas-CD40 as the optimal chimera for overcoming Fas ligand-mediated kill and enhancing CAR T-cell efficacy.

synthetic biology↗

Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV2 variants

The human angiotensin-converting enzyme 2 acts as the host cell receptor for SARS-CoV-2 and the other members of the Coronaviridae family SARS-CoV-1 and HCoV-NL63. Here we report the biophysical properties of the SARS-CoV-2 spike variants D614G, B.1.1.7 and B.1.351 with affinities to the ACE2 receptor and infectivity capacity, revealing weaknesses in the developed neutralising antibody approaches. Furthermore, we report a pre-clinical characterisation package for a soluble receptor decoy engineered to be catalytically inactive and immunologically inert, with broad neutralisation capacity, that represents an attractive therapeutic alternative in light of the mutational landscape of COVID-19. This construct efficiently neutralised four SARS-CoV-2 variants of concern. The decoy also displays antibody-like biophysical properties and manufacturability, strengthening its suitability as a first-line treatment option in prophylaxis or therapeutic regimens for COVID-19 and related viral infections.

immunology↗

Structural basis for the binding selectivity of human CDY chromodomains

The CDY (Chromodomain on the Y) family is a small family of chromodomain containing proteins, whose chromodomains closely resemble those in HP1 and Polycomb. The CDY proteins play an essential role in normal spermatogenesis and brain development. Dysregulation of their expression has been linked to male infertility and various neurological diseases. Like the chromodomains of HP1 and Polycomb, the CDY chromodomains also recognize the lysine-methylated ARKS motif embedded in histone and non-histone proteins. Interestingly, the CDY chromodomains exhibit different binding preferences for the lysine-methylated ARKS motif in different sequence contexts. Here, we present the structural basis for selective binding of CDY1 to H3K9me3 and preferential binding of CDYL2 to H3tK27me3 over H3K27me3. Based on our structural, binding and mutagenesis data, we synthesized a more CDYL1/2 selective peptidic ligand UNC4850. Our work provides critical implications that CDYL1bs role in the regulation of neural development is dependent on its recognition of lysine-methylated ARKS motifs.

molecular biology↗